Shennon Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Shennon Biotechnologies's estimated annual revenue is currently $1M per year.
- Shennon Biotechnologies's estimated revenue per employee is $77,500
Employee Data
- Shennon Biotechnologies has 13 Employees.
- Shennon Biotechnologies grew their employee count by 30% last year.
Shennon Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | CTO & Head Platform | Reveal Email/Phone |
Shennon Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Shennon Biotechnologies?
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8. www.shennonbio.com
keywords:N/AN/A
Total Funding
13
Number of Employees
$1M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 13 | -35% | $2.3M |
#2 | $0.4M | 13 | -28% | $52.7M |
#3 | $0.5M | 13 | 18% | $19M |
#4 | $0.4M | 13 | 0% | $27.1M |
#5 | $0.4M | 13 | -24% | $30.2M |